Biotia
Cornell Biotech Startup Makes Big Strides in Medicine Thanks to $2.4M Investment
|
The latest cash infusion will help the company — which aims to leverage artificial intelligence to more effectively fight infectious diseases — develop and introduce its products to a broader market, according to company founder and CEO Dr. Niamh O’Hara.
